NZ start-up's ginger-based rheumatoid arthritis therapy in clinical trials

NZ start-up's ginger-based rheumatoid arthritis therapy in clinical trials
Evithé Biotechnology founder Cynthia Hunefeld. (Image: Supplied)
Greg Hurrell
A New Zealand start-up is carrying out phase one clinical trials of its rheumatoid arthritis therapy based on the ginger plant.Evithé Biotechnology is a spinout company from Victoria University developing botanical and multi-target pharmaceutical prescription drugs from ginger rhizomes.Beyond rheumatoid arthritis, the company has a pipeline of botanical and pharmaceutical prescription drugs that could get to the root of other inflammatory disorders such as Alzheimer’s disease and sepsis.It hopes to have its first therapies on the m...

More Editor's Picks

Libelle's downfall raises procurement process question
Editor's Picks Exclusive

Libelle's downfall raises procurement process question

Plus: The Pita Pit and Subway deal that could have been. 

Cécile Meier 12 Mar 2025
Milking the Markets: Potential Mainland IPO taking shape
Primary Sector

Milking the Markets: Potential Mainland IPO taking shape

René Dedoncker and Paul Victor are racking up Airpoints this week.

Riley Kennedy 11 Mar 2025
Port retries fast-track bid after little blue penguin setback
Infrastructure

Port retries fast-track bid after little blue penguin setback

Port of Auckland is seeking consent for two major wharf projects.

Oliver Lewis 10 Mar 2025
Tech titans eye NZ's new golden visas
Policy

Tech titans eye NZ's new golden visas

Investors with tens of millions were 'priced out of the market'. Not any more.